Article

Vorinostat induced cellular stress disrupts the p38 mitogen activated protein kinase and extracellular signal regulated kinase pathways leading to apoptosis in Waldenström macroglobulinemia cells.

Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
Leukemia & lymphoma (impact factor: 2.4). 06/2011; 52(9):1777-86. DOI:10.3109/10428194.2011.577850 pp.1777-86
Source: PubMed

ABSTRACT Histone deacetylases (HDACs) are aberrantly expressed, and inhibitors of HDACs induce apoptosis in lymphoplasmacytic cells (LPCs) in Waldenström macroglobulinemia (WM). The molecular profile by which these agents induce apoptosis in WM LPCs remains to be delineated. We examined the activity of the histone deacetylase inhibitor, vorinostat, and dissected its pro-apoptotic pathways in WM LPCs. Vorinostat induced apoptosis in WM cells through activating specific caspases at varying times. Inhibitors of apoptosis (IAPs) were down-regulated after vorinostat treatment. Cellular stress induced in vorinostat-treated WM cells was reflected by changes in the mitogen activated protein kinase (MAPK) pathways. Activated phospho-p38 MAPK was up-regulated at 12 h, while phospho-extracellular signal-regulated kinase (Erk) abruptly decreased at 24 h. Bortezomib did not augment vorinostat induced primary WM cell killing as reported in other B-cell disorders. These studies support that stress induced apoptosis in vorinostat-treated WM LPCs is mediated through disrupting the activity of the Erk and p38 MAPK pathways.

0 0
 · 
0 Bookmarks
 · 
39 Views

Keywords

Activated phospho-p38 MAPK
 
activating specific caspases
 
agents induce apoptosis
 
B-cell disorders
 
Cellular stress induced
 
HDACs induce apoptosis
 
histone deacetylase inhibitor
 
Histone deacetylases
 
lymphoplasmacytic cells
 
mitogen activated protein kinase
 
p38 MAPK pathways
 
phospho-extracellular signal-regulated kinase
 
pro-apoptotic pathways
 
stress induced apoptosis
 
varying times
 
Vorinostat induced apoptosis
 
vorinostat induced primary WM cell
 
vorinostat-treated WM cells
 
vorinostat-treated WM LPCs
 
WM cells